Baiyong Li

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 171 citations

Oncology, Medicine, Advanced Solid Tumours +8

Role of the Guanosine Triphosphatase Rac2 in T Helper 1 Cell Differentiation

Baiyong Li, Hong Yu, Wei-ping Zheng et al. · Science · 2000 · 169 citations

Active Rac2, Molecular Regulation, Whereas Th2 Cells +19

GADD45γ Mediates the Activation of the p38 and JNK MAP Kinase Pathways and Cytokine Production in Effector TH1 Cells

Binfeng Lu, Hong Yu, Chi-wing Chow et al. · Immunity · 2001 · 164 citations · Full text

Cytokine, Effector Th1 Cells, Signal Transduction +9

Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity

Xinghua Pang, Zhaoliang Huang, Tingting Zhong et al. · mAbs · 2023 · 154 citations · Full text

Immunocytochemical Technique, Immunology, Immunodominance +17

<i>N</i> -Acetylglucosaminyltransferase V (Mgat5)-Mediated <i>N</i> -Glycosylation Negatively Regulates Th1 Cytokine Production by T Cells

Rodney Morgan, Guoyan Gao, Judy Pawling et al. · The Journal of Immunology · 2004 · 152 citations · Full text